Please use this identifier to cite or link to this item: https://dipositint.ub.edu/dspace/handle/2445/208090
Title: Gemini imidazolium gels enhance the photodynamic performance of porphyrins
Author: Anguluri, Kavya
Bagherpour, Saman
Abelha, Thais F.
Pérez García, M. Lluïsa (Maria Lluïsa)
Keywords: Compostos heterocíclics
Química farmacèutica
Heterocyclic compounds
Pharmaceutical chemistry
Issue Date: 27-Mar-2023
Publisher: Elsevier
Abstract: Photodynamic therapy (PDT) successful clinical use has led to an emerging interest in the development of improved delivery systems for photosensitizers. Amongst different formulations, gels have the advantage of being easier to apply, providing greater adhesion to the affected region and allowing light penetration. Importantly, we have previously reported that by incorporating porphyrin into a bisimidazolium gelator matrix there is an increased reactive oxygen species (ROS) generation compared to the photosensitizer in solution [1]. Motivated by this, we report further assessment on the photosensitizing capabilities of porphyrins in a gel structure. In this work, we evaluated effect of varying the chemical structures of porphyrins on their photosensitizing capabilities whilst embedded within a supramolecular hydrogel based on gemini imidazolium amphiphiles. The investigated porphyrins presented enhanced singlet oxygen (1O2) within the hydrogel matrix compared to solution and showed negligent release in relevant biological media. Rheological measurements revealed that porphyrin hydrogels presented desirable viscoelastic properties as a functional delivery system for PDT.
Note: Versió postprint del document publicat a:
It is part of: Photodiagnosis and Photodynamic Therapy, 2023, vol. 41, p. 103447
URI: https://hdl.handle.net/2445/208090
ISSN: 1572-1000
Appears in Collections:Articles publicats en revistes (Farmacologia, Toxicologia i Química Terapèutica)

Files in This Item:
File Description SizeFormat 
846974.pdf201.38 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons